Michael S. Diamond
Michael S. Diamond is a biomedical researcher, physician-scientist specializing in virology and immunology, with a particular emphasis on emerging RNA viruses such as flaviviruses, alphaviruses, and coronaviruses. He is a professor at Washington University School of Medicine, where he holds the Herbert S. Gasser Professorship of Medicine.
Biography
[edit]Diamond was born in Queens, New York City. He earned his Bachelor of Arts from Columbia University and both his Doctor of Medicine and Doctor of Philosophy in Cell and Developmental Biology from Harvard Medical School and Harvard University. He completed his residency in internal medicine and fellowship in infectious diseases at the University of California, San Francisco, followed by postdoctoral training at the University of California, Berkeley.
In 2001, Diamond established his laboratory at Washington University School of Medicine, where he currently holds the position of Herbert S. Gasser Professor of Medicine, Molecular Microbiology, and Pathology & Immunology.[1] Diamond is also the associate director for the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs.[2]
Research
[edit]Diamond's research focuses on emerging RNA viruses, including Zika, West Nile, chikungunya, and SARS-CoV-2, with an emphasis on understanding how these viruses cause illness and evade immune responses.[3] Notably, in 2020, Diamond and his team developed mouse models for SARS-CoV-2, which has been instrumental in facilitating research into COVID-19 vaccines, including a nasal vaccine that was tested in mice, hamsters, and non-human primates.[4]
Honors
[edit]- Elected member of American Society for Clinical Investigation in 2007[5]
- AAAS Fellow, 2017[6]
- Elected member of the National Academy of Medicine in 2018.[7]
- 2019 ASCI/Stanley J. Korsmeyer prize[8]
- Fellow of the National Academy of Inventors in 2020[9]
- Elected Councilor for the Association of American Physicians[10]
- Elected member of the National Academy of Sciences in 2024[11]
References
[edit]- ^ Wightman, Susan (31 May 2017). "Diamond named Gasser Professor of Medicine". Division of Infectious Diseases.
- ^ "$10 million gift creates Bursky Center for Human Immunology and Immunotherapy". washu.edu. 26 September 2016.
- ^ "Human antibody for Zika virus promising for treatment, prevention - Department of Biological Sciences". purdue.edu.
- ^ "Scientists identify antivirus system". washu.edu. 17 November 2010.
- ^ "Michael S. Diamond, MD, PhD". The American Society for Clinical Investigation.
- ^ "2017 AAAS Fellows Recognized for Advancing Science | American Association for the Advancement of Science (AAAS)". aaas.org.
- ^ "National Academy of Medicine Elects 85 New Members". NAM.
- ^ Jackson, Sarah (1 April 2019). "Infectious disease expert Michael S. Diamond wins the 2019 ASCI/Stanley J. Korsmeyer prize". The Journal of Clinical Investigation. pp. 1405–1406. doi:10.1172/JCI128050.
- ^ "Fellows". NAI.
- ^ "2024 - 2025 AAP Officers". Association of American Physicians.
- ^ Wightman, Susan (15 May 2024). "Michael S. Diamond elected to National Academy of Science". Washington University in St. Louis.
External links
[edit]- Michael S. Diamond publications indexed by Google Scholar